Decoupling peptide binding from T cell receptor recognition with engineered chimeric MHC-I molecules
暂无分享,去创建一个
N. Sgourakis | Devin Dersh | G. Papadaki | M. C. Young | Yi Sun | O. Ani | Tyler J. Florio | Julia N Danon | M. Young
[1] P. Flicek,et al. The IPD-IMGT/HLA Database , 2022, Nucleic Acids Res..
[2] E. Newell,et al. NY-ESO-1-specific redirected T cells with endogenous TCR knockdown mediate tumor response and cytokine release syndrome , 2022, Journal for ImmunoTherapy of Cancer.
[3] Amber K Weiner,et al. RETRACTED ARTICLE: Cross-HLA targeting of intracellular oncoproteins with peptide-centric CARs , 2021, Nature.
[4] C. Szeto,et al. The pockets guide to HLA class I molecules , 2021, Biochemical Society transactions.
[5] Nianzhi Zhang,et al. The Structure of a Peptide-Loaded Shark MHC Class I Molecule Reveals Features of the Binding between β2-Microglobulin and H Chain Conserved in Evolution , 2021, The Journal of Immunology.
[6] P. Bork,et al. Interactive Tree Of Life (iTOL) v5: an online tool for phylogenetic tree display and annotation , 2021, Nucleic Acids Res..
[7] H. Juan,et al. Connecting MHC-I-binding motifs with HLA alleles via deep learning , 2021, Communications Biology.
[8] K. Rock,et al. Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation , 2021, Frontiers in Immunology.
[9] L. Hellman,et al. Structurally silent peptide anchor modifications allosterically modulate T cell recognition in a receptor-dependent manner , 2021, Proceedings of the National Academy of Sciences.
[10] Brian D. Weitzner,et al. Macromolecular modeling and design in Rosetta: recent methods and frameworks , 2020, Nature Methods.
[11] Morten Nielsen,et al. NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data , 2020, Nucleic Acids Res..
[12] B. Jakobsen,et al. TCRs with Distinct Specificity Profiles Use Different Binding Modes to Engage an Identical Peptide–HLA Complex , 2020, The Journal of Immunology.
[13] Pemra Ozbek,et al. Sequence-structure-function relationships in class I MHC: A local frustration perspective , 2019, bioRxiv.
[14] J. Maris,et al. High throughput pMHC-I tetramer library production using chaperone-mediated peptide exchange , 2019, Nature Communications.
[15] David F. Boyd,et al. Human CD8+ T cell cross-reactivity across influenza A, B and C viruses , 2019, Nature Immunology.
[16] L. Pease,et al. Breaking tolerance with engineered class I antigen-presenting molecules , 2019, Proceedings of the National Academy of Sciences.
[17] Alessandro Sette,et al. The Immune Epitope Database (IEDB): 2018 update , 2018, Nucleic Acids Res..
[18] Jedd D. Wolchok,et al. Cancer immunotherapy using checkpoint blockade , 2018, Science.
[19] J. Utikal,et al. Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer , 2017, Nature.
[20] Charles H. Yoon,et al. An immunogenic personal neoantigen vaccine for patients with melanoma , 2017, Nature.
[21] P. Parham,et al. Distinguishing functional polymorphism from random variation in the sequences of >10,000 HLA-A, -B and -C alleles , 2017, PLoS genetics.
[22] Peter Schuck,et al. An allosteric site in the T-cell receptor Cβ domain plays a critical signalling role , 2017, Nature Communications.
[23] Zhiping Weng,et al. ATLAS: A database linking binding affinities with structures for wild‐type and mutant TCR‐pMHC complexes , 2017, Proteins.
[24] Thomas E. Royce,et al. Sequences of 95 human MHC haplotypes reveal extreme coding variation in genes other than highly polymorphic HLA class I and II , 2017, Genome research.
[25] Y. Wang,et al. Differential scanning fluorimetry based assessments of the thermal and kinetic stability of peptide-MHC complexes. , 2016, Journal of immunological methods.
[26] J. Oscherwitz. The promise and challenge of epitope-focused vaccines , 2016, Human vaccines & immunotherapeutics.
[27] Sudhir Kumar,et al. MEGA7: Molecular Evolutionary Genetics Analysis Version 7.0 for Bigger Datasets. , 2016, Molecular biology and evolution.
[28] Zhiping Weng,et al. How structural adaptability exists alongside HLA-A2 bias in the human αβ TCR repertoire , 2016, Proceedings of the National Academy of Sciences.
[29] W. Pickl,et al. On Peptides and Altered Peptide Ligands: From Origin, Mode of Action and Design to Clinical Application (Immunotherapy) , 2016, International Archives of Allergy and Immunology.
[30] Robert Weissert,et al. Antigen Presentation, Autoantigens, and Immune Regulation in Multiple Sclerosis and Other Autoimmune Diseases , 2015, Front. Immunol..
[31] H. W. V. van Deutekom,et al. Zooming into the binding groove of HLA molecules: which positions and which substitutions change peptide binding most? , 2015, Immunogenetics.
[32] W. Winnall,et al. Bacterial cytoplasmic display platform Retained Display (ReD) identifies stable human germline antibody frameworks. , 2015, Biotechnology journal.
[33] James McCluskey,et al. T cell antigen receptor recognition of antigen-presenting molecules. , 2015, Annual review of immunology.
[34] Ton N. Schumacher,et al. Adoptive cellular therapy: A race to the finish line , 2015, Science Translational Medicine.
[35] T. Schumacher,et al. Altered Peptide Ligands Revisited: Vaccine Design through Chemically Modified HLA-A2–Restricted T Cell Epitopes , 2014, The Journal of Immunology.
[36] Morten Nielsen,et al. Uncovering the Peptide-Binding Specificities of HLA-C: A General Strategy To Determine the Specificity of Any MHC Class I Molecule , 2014, The Journal of Immunology.
[37] R. K. Bright,et al. Overexpressed oncogenic tumor-self antigens , 2014, Human vaccines & immunotherapeutics.
[38] Xavier Robert,et al. Deciphering key features in protein structures with the new ENDscript server , 2014, Nucleic Acids Res..
[39] David Baker,et al. Proof of principle for epitope-focused vaccine design , 2014, Nature.
[40] E. Adams,et al. The adaptable major histocompatibility complex (MHC) fold: structure and function of nonclassical and MHC class I-like molecules. , 2013, Annual review of immunology.
[41] Peter Cresswell,et al. Pathways of antigen processing. , 2013, Annual review of immunology.
[42] R. Cagliani,et al. Pathogen-Driven Selection in the Human Genome , 2013, International Journal of Evolutionary Biology.
[43] A. Singer,et al. MHC restriction is imposed on a diverse T cell receptor repertoire by CD4 and CD8 co-receptors during thymic selection. , 2012, Trends in immunology.
[44] Morten Nielsen,et al. Seq2Logo: a method for construction and visualization of amino acid binding motifs and sequence profiles including sequence weighting, pseudo counts and two-sided representation of amino acid enrichment and depletion , 2012, Nucleic Acids Res..
[45] D. Price,et al. A Single Autoimmune T Cell Receptor Recognizes More Than a Million Different Peptides* , 2011, The Journal of Biological Chemistry.
[46] D. Higgins,et al. Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega , 2011, Molecular systems biology.
[47] Vincent B. Chen,et al. Correspondence e-mail: , 2000 .
[48] L. K. Ely,et al. The molecular basis of TCR germline bias for MHC is surprisingly simple , 2009, Nature Immunology.
[49] Philippa Marrack,et al. Evolutionarily conserved amino acids that control TCR-MHC interaction. , 2008, Annual review of immunology.
[50] T. Schumacher,et al. Conditional MHC class I ligands and peptide exchange technology for the human MHC gene products HLA-A1, -A3, -A11, and -B7 , 2008, Proceedings of the National Academy of Sciences.
[51] L. K. Ely,et al. T cell allorecognition and MHC restriction--A case of Jekyll and Hyde? , 2008, Molecular immunology.
[52] Bjoern Peters,et al. HLA class I supertypes: a revised and updated classification , 2008, BMC Immunology.
[53] A. Sewell,et al. Different T Cell Receptor Affinity Thresholds and CD8 Coreceptor Dependence Govern Cytotoxic T Lymphocyte Activation and Tetramer Binding Properties* , 2007, Journal of Biological Chemistry.
[54] T. Schumacher,et al. Generation of peptide–MHC class I complexes through UV-mediated ligand exchange , 2006, Nature Protocols.
[55] Robyn L Stanfield,et al. How TCRs bind MHCs, peptides, and coreceptors. , 2006, Annual review of immunology.
[56] T. Schumacher,et al. Design and use of conditional MHC class I ligands , 2006, Nature Medicine.
[57] E. Andrès,et al. Clinical and immunological aspects of HLA class I deficiency. , 2005, QJM : monthly journal of the Association of Physicians.
[58] F. Balloux,et al. Pathogen-Driven Selection and Worldwide HLA Class I Diversity , 2005, Current Biology.
[59] Andrew Sewell,et al. Structural and kinetic basis for heightened immunogenicity of T cell vaccines , 2005, The Journal of experimental medicine.
[60] L. K. Ely,et al. Natural HLA Class I Polymorphism Controls the Pathway of Antigen Presentation and Susceptibility to Viral Evasion , 2004, The Journal of experimental medicine.
[61] M. Bouvier,et al. Structures of HLA-A*1101 Complexed with Immunodominant Nonamer and Decamer HIV-1 Epitopes Clearly Reveal the Presence of a Middle, Secondary Anchor Residue1 , 2004, The Journal of Immunology.
[62] Ron D. Appel,et al. ExPASy: the proteomics server for in-depth protein knowledge and analysis , 2003, Nucleic Acids Res..
[63] James Robinson,et al. IMGT/HLA and IMGT/MHC: sequence databases for the study of the major histocompatibility complex , 2003, Nucleic Acids Res..
[64] W. Potts,et al. MHC heterozygosity confers a selective advantage against multiple-strain infections , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[65] A. Casrouge,et al. A Direct Estimate of the Human αβ T Cell Receptor Diversity , 1999 .
[66] N. G. Saito,et al. Recognition of an MHC class I-restricted antigenic peptide can be modulated by para-substitution of its buried tyrosine residues in a TCR-specific manner. , 1999, Journal of immunology.
[67] J. Yewdell,et al. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. , 1999, Annual review of immunology.
[68] D. Margulies,et al. Three-dimensional structure of H-2Dd complexed with an immunodominant peptide from human immunodeficiency virus envelope glycoprotein 120. , 1998, Journal of molecular biology.
[69] Philip J. R. Goulder,et al. Phenotypic Analysis of Antigen-Specific T Lymphocytes , 1996, Science.
[70] D. Wiley,et al. HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[71] H. Rammensee,et al. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules , 1991, Nature.
[72] M. A. Saper,et al. Structure of the human class I histocompatibility antigen, HLA-A2 , 1987, Nature.